@calxshreds's TRT supplement claims need fact-checking
Quick answer
The creator is addressing side effects common to both prescribed TRT and unsupervised supraphysiologic androgen use, without distinguishing between the two populations or acknowledging that several recommendations involve prescription-only medications. Multiple organ systems are discussed, including cardiovascular, hepatic, renal, dermatological, and psychiatric, and the interventions suggested span experimental compounds, off-label drugs, and supplements with highly variable evidence quality. Anyone experiencing the symptoms described, including elevated liver enzymes, reduced eGFR, or polycythemia, should be evaluated by a physician before adding any further compounds.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @calxshreds actually say?
This creator ran through eight common TRT and anabolic cycle side effects, including high blood pressure, acne, liver stress, kidney strain, hair loss, thick blood, lipid changes, and mental health issues, and offered a compound-heavy fix for each one. The advice ranged from genuinely reasonable lifestyle tweaks to recommending prescription medications, experimental compounds like RU58841, and injectable glutathione stacks, all without a medical disclaimer in sight. The creator also name-dropped GLP-1 receptor agonists without saying the name, told viewers to take telmisartan and metformin, and suggested methylene blue for both blood viscosity and mood. The through-line is that every side effect has a pharmaceutical or supplement workaround, which is a framing that should give anyone pause.
Does the science back this up?
Some of it, yes. A lot of it, not well. The creator is working in a space where the evidence base is genuinely thin, because most of the interventions they recommend have never been formally studied in the context of supraphysiologic androgen use. The few that have real data behind them, like telmisartan for blood pressure and finasteride for DHT-driven hair loss, are legitimate. But the evidence for others, like "injectable glutathione" as an antioxidant therapy or methylene blue for blood viscosity, is either preliminary, misapplied, or frankly cherry-picked. Telmisartan does have modest LDL-lowering data, but the 2011 ONTARGET subgroup analyses found the effect was primarily in obese hypertensive patients, and generalizing that to otherwise-healthy people using anabolics is a stretch. Berberine has reasonable glucose-disposal data in type 2 diabetic populations (Yin et al., 2008, Metabolism), but again, extrapolating that to anabolic-cycle insulin management is not the same thing.
What did they get wrong (or right)?
Credit where it is due: swapping cotton for silk sheets to reduce acne-triggering bacterial load is low-risk and has dermatological logic behind it. Recommending finasteride or dutasteride for DHT conversion during testosterone use is standard harm-reduction advice. Telling people not to use oral androgens if liver enzymes are elevated is correct. Encouraging frequent pinning to stabilize hormone levels is also a widely accepted TRT practice.
But here is where it falls apart. Recommending RU58841, an experimental androgen receptor antagonist that was abandoned in clinical trials and has never been approved anywhere, as a casual topical add-on is not appropriate for a TikTok. The safety profile in humans is essentially unknown. The creator also says "10 to 20 milligrams of Cialis daily" for blood pressure, which conflates tadalafil's modest vasodilatory effect with actual antihypertensive therapy. Tadalafil is not a first-line or even second-line treatment for hypertension. Presenting it that way is misleading. The claim that TUDCA and injectable glutathione will protect a liver that is under anabolic stress is also overstated. TUDCA has some hepatoprotective data (Vang et al., 2014, Hepatology), but injectable glutathione as a practical clinical intervention for steroid-induced enzyme elevation has almost no peer-reviewed support.
What should you actually know?
If you are on TRT prescribed by a physician and your blood pressure, lipids, kidney function, or liver enzymes are moving in the wrong direction, the correct first step is telling that physician, not building a supplement stack from a TikTok video. Several of the compounds discussed here, including telmisartan, metformin, finasteride, and dutasteride, are prescription medications in most countries. Recommending them without a consult is not harm reduction. It is unsupervised polypharmacy. RU58841 in particular has no regulatory approval anywhere and no long-term human safety data. The mental health section is the most responsible part of the video, where the creator correctly notes that high androgen loads can drive mania and recommends reducing dose and pinning frequency. That part is grounded. The rest of the video, however, frames serious physiological warning signs as engineering problems to be optimized around rather than signals to reduce or stop use, and that framing is where the real risk lives.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 8 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For @calxshreds's TRT supplement claims need fact-checking, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Ipamorelin, the first selective growth hormone secretagogue
Background source for ipamorelin selectivity and GH-secretagogue mechanism.
PubMed
The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation
Preclinical context that should not be overstated as consumer clinical evidence.
PubMed
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
Video claim decision path
Turn the claim into a safer next question
Direct answer
@calxshreds's TRT supplement claims need fact-checking should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.
Evidence check
Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.
Safety check
A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.
Next step
Use the health tools and supporting evidence to prepare questions for your clinician.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
The creator is addressing side effects common to both prescribed TRT and unsupervised supraphysiologic androgen use, without distinguishing between the two populations or acknowledging that several recommendations involve prescription-only medications.
FormBlends verdict
The creator is addressing side effects common to both prescribed TRT and unsupervised supraphysiologic androgen use, without distinguishing between the two populations or acknowledging that several recommendations involve prescription-only medications. Multiple organ systems are discussed, including cardiovascular, hepatic, renal, dermatological, and psychiatric, and the interventions suggested span experimental compounds, off-label drugs, and supplements with highly variable evidence quality. Anyone experiencing the symptoms described, including elevated liver enzymes, reduced eGFR, or polycythemia, should be evaluated by a physician before adding any further compounds.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The creator is addressing side effects common to both prescribed TRT and unsupervised supraphysiologic androgen use, without distinguishing between the two populations or acknowledging that several recommendations involve prescription-only medications. Multiple organ systems are discussed, including cardiovascular, hepatic, renal, dermatological, and psychiatric, and the interventions suggested span experimental compounds, off-label drugs, and supplements with highly variable evidence quality. Anyone experiencing the symptoms described, including elevated liver enzymes, reduced eGFR, or polycythemia, should be evaluated by a physician before adding any further compounds.
- Telmisartan's LDL-lowering effect, referenced by the creator, comes primarily from subgroup data in obese hypertensive patients (ONTARGET, 2011) and should not be generalized to healthy individuals using anabolics.
- RU58841 has never completed human clinical trials and has no regulatory approval in any country. Its long-term safety profile is unknown and it should not be recommended in public-facing content.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Telmisartan's LDL-lowering effect, referenced by the creator, comes primarily from subgroup data in obese hypertensive patients (ONTARGET, 2011) and should not be generalized to healthy individuals using anabolics.
- RU58841 has never completed human clinical trials and has no regulatory approval in any country. Its long-term safety profile is unknown and it should not be recommended in public-facing content.
- Tadalafil is not an antihypertensive medication. Using it in place of first-line agents like ACE inhibitors or ARBs for TRT-related blood pressure elevation is pharmacologically incorrect and potentially dangerous.
- Several compounds discussed, including telmisartan, metformin, finasteride, and dutasteride, are prescription-only medications in most jurisdictions and require physician oversight before use.
- Berberine showed HbA1c reductions comparable to metformin in a small 2008 trial (Yin et al., Metabolism), but this was in type 2 diabetic patients, not people using exogenous androgens or growth hormone.
- The creator correctly identifies that high androgen loads and supraphysiologic doses increase mania risk, and the recommendation to reduce dose and stabilize levels through more frequent administration reflects standard harm-reduction logic.
- Elevated liver enzymes, reduced eGFR, or polycythemia during androgen use are clinical warning signs that warrant stopping or reducing the offending compound and consulting a physician, not adding more compounds to the stack.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Calxshredz · TikTok creator
13.9K views on this video
Save this for later! For more information join the chat in my bio #FYP #viral #supplements #tik_tok #gym
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Calxshredz, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.